Nuvectis Pharma Inc (NVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | NVCT | OPT | ATHA | ||
Company | Nuvectis Pharma Inc | Opthea Ltd ADR | Athira Pharma Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 6.81 | 2.14 | 3.12 | ||
High | 6.82 | 2.26 | 3.24 | ||
Low | 6.56 | 2.06 | 3.06 | ||
Last | 6.74 | 2.09 | 3.24 | ||
Change | +0.02 | -0.03 | +0.13 | ||
% Change | +0.30% | -1.42% | +4.18% | ||
Volume | 15,549 | 16,197 | 86,495 | ||
20-Day Average Volume | 111,037 | 18,415 | 143,730 | ||
Previous Close | 6.72 | 2.12 | 3.11 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 6.53 | 1.98 | 2.90 | ||
20-Day Raw Stochastic | 52.11% | 62.50% | 75.51% | ||
20-Day Relative Strength | 51.56% | 39.64% | 61.18% | ||
Weighted Alpha | -57.74 | -28.53 | +20.28 | ||
Today's Opinion | 48% Sell | 72% Sell | 88% Buy | ||
Previous Opinion | 48% Sell | 72% Sell | 88% Buy | ||
Last Month's Opinion | 72% Sell | 24% Sell | 48% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +1.35% since 07/15/24 | unch since 07/15/24 | -3.57% since 07/15/24 | ||
Low | 6.45 on 07/18/24 | 2.05 on 07/16/24 | 3.06 on 07/22/24 | ||
High | 7.01 on 07/16/24 | 2.26 on 07/22/24 | 3.44 on 07/18/24 | ||
1-Month | |||||
%Chg | -4.40% since 06/21/24 | +4.50% since 06/21/24 | +38.46% since 06/21/24 | ||
Low | 6.00 on 06/28/24 | 1.79 on 06/27/24 | 2.13 on 06/25/24 | ||
High | 7.42 on 06/26/24 | 2.27 on 06/26/24 | 3.60 on 07/15/24 | ||
3-Month | |||||
%Chg | -5.07% since 04/22/24 | -38.17% since 04/22/24 | +55.02% since 04/22/24 | ||
Low | 5.85 on 05/20/24 | 1.79 on 06/27/24 | 1.89 on 04/25/24 | ||
High | 8.45 on 05/06/24 | 4.05 on 05/09/24 | 3.60 on 07/15/24 | ||
6-Month | |||||
%Chg | -5.47% since 01/22/24 | -25.09% since 01/22/24 | +5.54% since 01/22/24 | ||
Low | 5.85 on 05/20/24 | 1.79 on 06/27/24 | 1.89 on 04/25/24 | ||
High | 12.10 on 03/14/24 | 4.40 on 04/01/24 | 4.30 on 02/21/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 123,352 | 123,797 | 119,203 | ||
Shares Outstanding, K | 18,356 | 58,395 | 38,329 | ||
Annual Sales | 0 | 110,000 | 0 | ||
Annual Net Income | -22,260,000 | -142,520,000 | -117,670,000 | ||
Last Quarter Sales | 0 | N/A | 0 | ||
Last Quarter Net Income | -4,170,000 | N/A | -26,340,000 | ||
60-Month Beta | 0.46 | 1.12 | 2.90 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.25 on 05/07/24 | N/A | -0.69 on 05/15/24 | ||
Latest Earnings Date | 08/14/24 | 08/29/24 | 08/08/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |